Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration

Obstetrics and Gynecology
Colleen McNicholasJeffrey F Peipert

Abstract

To evaluate the effectiveness of the contraceptive implant and the 52-mg hormonal intrauterine device (IUD) in women using the method beyond the current U.S. Food and Drug Administration (FDA)-approved duration of 3 and 5 years, respectively. Women willing to continue using their implant or 52-mg levonorgestrel IUD beyond the FDA-approved duration were followed prospectively for contraceptive effectiveness. Unintended pregnancy rate per 100 women-years was calculated. Implant users are offered periodic venipuncture for analysis of serum etonogestrel levels. The Kruskal-Wallis test was used to compare the etonogestrel levels across body mass index (BMI) groups. Implant users (n=237) have contributed 229.4 women-years of follow-up, with 123 using the etonogestrel implant for 4 years and 34 using it for 5 years. Zero pregnancies have been documented, for a failure rate of 0 (one-sided 97.5% confidence interval [CI] 0-1.61) per 100 women-years. Among 263 levonorgestrel IUD users, 197.7 women-years of follow-up have been completed. One pregnancy was confirmed, for a failure rate of 0.51 (95% CI 0.01-2.82) per 100 women-years. Among implant users with serum etonogestrel results, the median and range of etonogestrel level at 3 years o...Continue Reading

References

Oct 1, 1991·Contraception·S DíazH B Croxatto
Aug 26, 1998·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·O KiriwatH J Bennink
Mar 30, 1999·Contraception·J Huber, R Wenzl
Mar 30, 1999·Contraception·H B Croxatto, L Mäkäräinen
Nov 16, 1999·American Journal of Obstetrics and Gynecology·R RiveraD Grimes
Feb 8, 2002·Obstetrical & Gynecological Survey·David Hubacher, David A Grimes
Aug 9, 2008·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Olivier Graesslin, Tjeerd Korver
Jan 15, 2010·JAMA : the Journal of the American Medical Association·Katherine M FlegalLester R Curtin
Jun 15, 2010·American Journal of Obstetrics and Gynecology·Gina M SecuraJeffrey F Peipert
Jul 17, 2010·Human Reproduction Update·P D BlumenthalK Gemzell-Danielsson
Apr 22, 2011·The New England Journal of Medicine·Kelly ClelandJames Trussell
Jun 22, 2012·American Journal of Obstetrics and Gynecology·Sara MornarMelissa Gilliam
Aug 30, 2012·Journal of Pediatric and Adolescent Gynecology·Amy G BryantSubasri Narasimhan
Nov 22, 2012·Obstetrics and Gynecology·Jeffrey F PeipertGina M Secura
Jan 12, 2013·Contraception·Lawrence B Finer, Adam Sonfield
Jan 30, 2013·Transplantation·Colleen M KrajewskiVeronica Gomez-Lobo
Apr 3, 2013·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Maureen K Baldwin, Alison B Edelman
Oct 2, 2014·The New England Journal of Medicine·Gina M SecuraJeffrey F Peipert

❮ Previous
Next ❯

Citations

Dec 3, 2015·Women's Health·Giuseppe BenagianoIvo Brosens
Aug 12, 2015·American Journal of Obstetrics and Gynecology·Justin T DiedrichJeffrey F Peipert
Sep 26, 2015·Current Treatment Options in Cardiovascular Medicine·Kathryn J LindleyTessa Madden
Nov 26, 2015·Obstetrics and Gynecology Clinics of North America·Shandhini Raidoo, Bliss Kaneshiro
Mar 24, 2016·American Journal of Obstetrics and Gynecology·Daniel P ChilesDavid A Klein
Jul 28, 2016·Contraception·Sam RowlandsMartyn Walling
Aug 28, 2016·Fertility and Sterility·Katharine B Simmons, Alison B Edelman
Sep 28, 2016·Human Reproduction·Moazzam AliUNKNOWN WHO study group on subdermal contraceptive implants for women
Feb 2, 2017·The New England Journal of Medicine·Kathryn M Curtis, Jeffrey F Peipert
Dec 19, 2016·American Journal of Obstetrics and Gynecology·Rachel E Zigler, Colleen McNicholas
Feb 21, 2018·Menopause : the Journal of the North American Menopause Society·Taniqua A MillerCarrie A Cwiak
May 6, 2019·BMJ Sexual & Reproductive Health
Dec 17, 2015·Menopause : the Journal of the North American Menopause Society·Rebecca H Allen, Carrie A Cwiak
Jun 21, 2020·Global Health, Science and Practice·Michelle WeinbergerJohn Skibiak
May 27, 2020·Clinical Obstetrics and Gynecology·Yasmin Z Bahar, Melanie A Gold
Sep 16, 2017·Expert Opinion on Pharmacotherapy·Laura BuggioPaolo Vercellini
Jun 13, 2020·The Cochrane Database of Systematic Reviews·Magdalena Bofill RodriguezVanessa Jordan
Nov 5, 2015·Current Opinion in Obstetrics & Gynecology·Jennifer Conti, Kate Shaw
Jan 26, 2018·Obstetrical & Gynecological Survey·Jessica Elizabeth Morse, Prutha Rohit Pathak
Apr 25, 2018·Contraception and Reproductive Medicine·Carrie Cwiak, Sarah Cordes
Oct 17, 2020·Open Access Journal of Contraception·Karen WeidertNdola Prata
Apr 23, 2021·Best Practice & Research. Clinical Obstetrics & Gynaecology·Bibi Zeyah Fatemah Sairally, T Justin Clark
Dec 15, 2020·Pharmacology & Therapeutics·Alexis J BickJanet P Hapgood
Jul 3, 2021·Pharmaceuticals·Morena Luigia RoccaCostantino Di Carlo
Sep 10, 2021·Seminars in Reproductive Medicine·Shandhini RaidooBliss Kaneshiro
Aug 31, 2016·Pediatrics·Athena P KourtisUNKNOWN COMMITTEE ON PEDIATRIC AIDS

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.